Baudax Bio, Inc. (BXRXQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Baudax Bio Shareholders Equity (Quarterly)
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -10.24M |
| June 30, 2023 | -10.68M |
| March 31, 2023 | -7.313M |
| December 31, 2022 | -24.24M |
| September 30, 2022 | -19.54M |
| June 30, 2022 | 4.23M |
| March 31, 2022 | 9.743M |
| December 31, 2021 | 13.23M |
| September 30, 2021 | -20.73M |
| June 30, 2021 | -4.573M |
| Date | Value |
|---|---|
| March 31, 2021 | -0.994M |
| December 31, 2020 | -14.80M |
| September 30, 2020 | -45.23M |
| June 30, 2020 | -59.40M |
| March 31, 2020 | -35.89M |
| December 31, 2019 | -16.72M |
| September 30, 2019 | -35.42M |
| June 30, 2019 | -29.19M |
| March 31, 2019 | -51.33M |
| December 31, 2018 | -68.35M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |